8217 — Ju Fu Tang Biotech Holdings Balance Sheet
0.000.00%
- HK$32.60m
- -HK$16.05m
- HK$37.56m
Annual balance sheet for Ju Fu Tang Biotech Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 44.7 | 44.2 | 26.7 | 30.2 | 60.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 91.7 | 56.3 | 49.6 | 40.6 | 26.9 |
| Total Other Current Assets | |||||
| Total Current Assets | 143 | 105 | 81.3 | 80.2 | 92.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.683 | 0.323 | 0.243 | 0.163 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 144 | 106 | 81.6 | 80.4 | 92.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 83.8 | 55 | 48.4 | 53.1 | 42.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 83.8 | 55 | 48.4 | 53.1 | 42.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 60.5 | 50.5 | 33.1 | 27.2 | 50.5 |
| Total Liabilities & Shareholders' Equity | 144 | 106 | 81.6 | 80.4 | 92.6 |
| Total Common Shares Outstanding |